Value through Innovation27 July 2016

Clinical Study Results

  • BUSCOPAN® PLUS - Gastrointestinal Diseases
    Clinical Study Number 218.202
    Study Indication Gastrointestinal Diseases
    Product BUSCOPAN® PLUS
    Generic Name Hyoscine butylbromide + Paracetamol
    Lab Code
    Clinical Phase II
    Study Title

    Buscopan® plus, Buscopan®, paracetamol and placebo: Double-blind randomized group comparison to investigate the efficacy and tolerability of the film-coated tablets in patients with painful gastric or intestinal spasms

    Study Document Trial synopsis 218.202 english
  • BUSCOPAN® PLUS - Abdominal Pain
    Clinical Study Number 218.705
    Study Indication Abdominal Pain
    Product BUSCOPAN® PLUS
    Generic Name Hyoscine butylbromide + Paracetamol
    Lab Code
    Clinical Phase IV
    Study Title

    Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima

    Study Document Trial synopsis 218.705 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.